Philadelphia, PA, United States of America

Fred Letterio


Average Co-Inventor Count = 1.4

ph-index = 3

Forward Citations = 603(Granted Patents)


Company Filing History:


Years Active: 1984-1988

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Fred Letterio: Innovator in Medical Technology

Introduction

Fred Letterio is a notable inventor based in Philadelphia, PA (US). He has made significant contributions to the field of medical technology, particularly in non-invasive methods for measuring blood glucose concentration. With a total of 3 patents to his name, Letterio's work has the potential to impact the lives of many individuals managing diabetes.

Latest Patents

One of his latest patents is a method and apparatus for measuring blood glucose concentration. This innovative approach provides a non-invasive way to measure glucose levels using the glucose present at the mucosal surface of a living being. The method involves positioning a glucose oxidase membrane on the mucosal surface, supplying oxygen for peroxidative oxidation of the glucose, and electrically measuring the amount of hydrogen peroxide produced. This measurement is then calibrated to determine the blood glucose concentration. Additionally, the patent includes electrode devices suitable for carrying out this method.

Career Highlights

Throughout his career, Fred Letterio has worked with various companies, including Xienta, Inc. His experience in the medical technology sector has allowed him to develop groundbreaking solutions that address critical health issues.

Collaborations

Fred has collaborated with notable individuals in his field, including Richard Reinhart and Peter Pugliese. These partnerships have contributed to the advancement of his innovative projects and patents.

Conclusion

Fred Letterio's contributions to medical technology, particularly in non-invasive glucose measurement, highlight his role as an influential inventor. His work continues to pave the way for advancements in healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…